Hamilton Thorne (HTL) Stock Price, News & Analysis

Company Overview

Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, laboratory equipment, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. The company offers precision laser systems and imaging systems for biology markets. It also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services. In addition, the company manufactures and distributes medical products for reproductive medicine; manufactures bespoke workstations, incubators, and equipment for IVF laboratories; researches, designs, develops, sells, installs, and services in-vitro diagnostic systems; and manufactures ovum pickup needles, catheters, and other devices. Further, the company offers Cell-Tek Microscope Chamber, a product for controlling temperature, air flow, humidification, and air quality; laminar flow workstations, incubators, and related products; and artificial intelligence enabled CASA software, consumables, and image analysis systems for the ART and laboratory markets, as well as capital equipment and consumables, software, and other services. It sells its products and services under Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, MICROPTIC, Gynétics, and Embryotech brand names through a direct sales force in the United States, Germany, France, Australia, Denmark, Belgium, Spain, and the United Kingdom, as well as through distributors to fertility clinics, hospitals, pharmaceutical companies, biotechnology companies, educational institutions, and other commercial and academic research establishments in approximately 100 countries. Hamilton Thorne Ltd. is headquartered in Beverly, Massachusetts.

Key Stats

• Today's Range: C$2.24 to C$2.25
• 50-Day Range: C$2.14 to C$2.25
• 52-Week Range: C$1.14 to C$2.25
• Volume: 15,400 shs
• Average Volume: 144,297 shs
• Market Capitalization: C$346.28 million
• P/E Ratio: N/A
• Dividend Yield: 1.50%
• Price Target: N/A
• Consensus Rating: N/A

HTL Stock Analysis - Frequently Asked Questions

How have HTL shares performed this year?

Hamilton Thorne's stock was trading at C$1.33 at the start of the year. Since then, HTL stock has increased by 69.2% and is now trading at C$2.25.
View the best growth stocks for 2024 here.

How do I buy shares of Hamilton Thorne?

Shares of HTL stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: TSE:HTL
• CUSIP: N/A
• CIK: N/A
• Web: www.hamiltonthorne.ltd
• Phone: 978-921-2050
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): C($0.02)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 47.58
• P/E Growth: N/A
• Net Income: C$-1,700,000.00
• Net Margins: -2.34%
• Pretax Margin: N/A
• Return on Equity: -2.79%
• Return on Assets: 0.31%

Debt

• Debt-to-Equity Ratio: 41.23
• Current Ratio: 1.78
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: C$72.57 million
• Price / Sales: 4.77
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: C$0.41 per share
• Price / Book: 5.49

Miscellaneous

• Outstanding Shares: 153,900,000
• Free Float: N/A
• Market Cap: C$346.28 million
• Optionable: Not Optionable
• Beta: 0.41